Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, Massachusetts
- Most recent report
- 8-K, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 796 filings
- On EDGAR
- CIK 1818794
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 25
News 8 of 66
Prospectuses and Registrations 8 of 28
- 424B5 Prospectus supplement for an offering Jul 22, 2026
- 424B5 Prospectus supplement for an offering Jul 21, 2026
- S-8 Registration statement for an employee plan Mar 27, 2026
- S-8 Registration statement for an employee plan Mar 2, 2026
- 424B5 Prospectus supplement for an offering Dec 10, 2025
- 424B5 Prospectus supplement for an offering Dec 8, 2025
- 424B5 Prospectus supplement for an offering Jul 1, 2025
- 424B5 Prospectus supplement for an offering Jun 30, 2025
Proxies 8 of 13
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- PRE 14A Preliminary proxy statement Apr 9, 2026
- DEFA14A Extra proxy material Apr 15, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 15, 2025
- DEFA14A Extra proxy material Apr 5, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 5, 2024
- DEFA14A Extra proxy material Apr 7, 2023
Ownership 8 of 638
- 4 Insider reported a trade Oct 22, 2026
- 4 Insider reported a trade Oct 6, 2026
- 144 Notice of a proposed sale of restricted stock Sep 8, 2026
- 144 Notice of a proposed sale of restricted stock Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
Other 8 of 26
- ARS Annual report sent to shareholders Apr 23, 2026
- ARS Annual report sent to shareholders Apr 15, 2025
- ARS Annual report sent to shareholders Apr 5, 2024
- S-3MEF Jan 4, 2024
- ARS Annual report sent to shareholders Apr 7, 2023
- EFFECT Notice that a registration became effective Nov 17, 2021
- CORRESP Reply to SEC staff Nov 15, 2021
- UPLOAD Comment letter from SEC staff Nov 10, 2021
Everything here comes from Dyne Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.